Gritstone bio to Participate in Upcoming Investor Conferences
EMERYVILLE, Calif., Jan. 18, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today announced that management will participate in the following investor conferences.
B. Riley Securities' 3rd Annual Oncology Conference (Fireside Chat)
2023 BIO CEO & Investor Conference (Panel)
SVB Securities Global Biopharma Conference (Fireside Chat)
ive webcast and/or archived replays will be available via https://ir.gritstonebio.com/investors/events. Archived replays will be accessible for at least 30 days following the corresponding event.
About Gritstone bio
ITEXPO, MSP Expo, The Blockchain Event, Future of Work Conference Sessions
Selling SD-WAN: A Key to MSP Success